Hit enter after type your search item

Gcp Definitions

/
/
/
15 Views

GCP Compliance (Clinical Trials)

Definitions:

Good Clinical Practice

ICH E6: A standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials that provides assurance that the data and reported results are credible and accurate, and that the rights, integrity, and confidentiality of trial subjects are protected (as per Section 1.27 of ICH E6)

EU Clinical Trials Directive: Good clinical practice is a set of internationally recognised ethical and scientific quality requirements which must be observed for designing, conducting, recording and reporting clinical trials that involve the participation of human subjects. Compliance with this good practice provides assurance that the rights, safety and well-being of trial subjects are protected, and that the results of the clinical trials are credible (as per Article 1.2 of Directive 2001/20/EC)

Clinical Trial

ICH E6: Any investigation in human subjects intended to discover or verify the clinical, pharmacological and/or other pharmacodynamic effects of an investigational product(s), and/or to identify any adverse reactions to an investigational product(s), and/or to study absorption, distribution, metabolism, and excretion of an investigational product(s) with the object of ascertaining its safety and/or efficacy (as per Section 1.12 of ICH E6)

EU Clinical Trial Directive (2001/20/EC): Any investigation in human subjects intended to discover or verify the clinical, pharmacological and/or other pharmacodynamic effects of one or more investigational medicinal product(s), and/or to identify any adverse reactions to one or more investigational medicinal product(s) and/or to study absorption, distribution, metabolism and excretion of one or more investigational medicinal product(s) with the object of ascertaining its (their) safety and/or efficacy. This includes clinical trials carried out in either one site or multiple sites, whether in one or more than one Member State (as per Article 2(a) of Directive 2001/20/EC)

EU Clinical Trial Regulation (EU/536/2014): Means a clinical study which fulfils any of the following conditions:
(a) the assignment of the subject to a particular therapeutic strategy is decided in advance and does not fall within normal clinical practice of the Member State concerned;
(b) the decision to prescribe the investigational medicinal products is taken together with the decision to include the subject in the clinical study; or
(c) diagnostic or monitoring procedures in addition to normal clinical practice are applied to the subjects.
(as per Article 2.2(2) of Regulation (EU) No 536/2014)

FDA: A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes. Clinical trials are interventional clinical studies (as per Glossary of Framework for FDA’s Real-World Evidence Program – Dec 2018)

Leave a Comment

Your email address will not be published. Required fields are marked *

This div height required for enabling the sticky sidebar